Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone in children with Pelizaeus-Merzbacher disease
NL-OMON60005Phase 2Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferiprone in Pelizaeus-Merzbacher disease (PMD), sponsored by Amsterdam University Medical Center. Started Dec 2024; status: recruiting.
02
Drugs
deferiprone
03
Conditions
Pelizaeus-Merzbacher disease (PMD)
Beyond the preview
Go deeper on NL-OMON60005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60005.